Document Detail

Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy.
MedLine Citation:
PMID:  22356659     Owner:  NLM     Status:  Publisher    
BACKGROUND: Approximately 30-40% of patients with Barrett's oesophagus (BE) patients manifest abnormal oesophageal pH profiles despite proton pump inhibitor (PPI) therapy. AIM: To determine control of oesophageal reflux using Bravo pH monitoring in patients BE on omeprazole-sodium bicarbonate oral suspension powder (Ome-NaBic) 40 mg twice daily. METHODS: Initial pH monitoring off PPI for 1 week was performed. All patients underwent repeat pH testing on Ome-NaBic administered before breakfast and at bedtime after 21-28 days of therapy depending upon the prior PPI therapy. The goal was to enroll 30 subjects, however, the trial was terminated prematurely when the sponsor lost financing due to a change in business strategy. RESULTS: A total of 88 patients responded to the study invitation, 27 patients signed informed consent, and 21 patients underwent pH testing of PPI. A total of 15 patients completed the protocol (13 men, 2 women). Demographic information for patients completing at least one Bravo study included a mean (±s.d.) age 62 ± 9 years; body mass index 31 ± 8 kg/m(2) (range 23-48); mean BE length of 2.6 ± 2 cm; 9 (43%) patients with long segment BE. All (100%) patients demonstrated normalisation of supine pH on both days of Ome-NaBic therapy. One patient (6%) demonstrated abnormal upright reflux on the second day of monitoring on Ome-NaBic therapy; all the other patients demonstrated normal pH scores on therapy. CONCLUSIONS: Administration of twice daily Ome-NaBic demonstrated control of nocturnal oesophageal reflux in 100% of patients with Barrett's oesophagus, and complete control of oesophageal pH during 97% of the 24-h recording periods.
L B Gerson; S Mitra; W F Bleker; P Yeung
Related Documents :
2861409 - Can antigliadin antibody detect symptomless coeliac disease in children with short stat...
22496069 - Emergency department imaging protocol for suspected acute renal colic: re-evaluating ou...
17511739 - Usefulness of laparo- or retroperitoneoscopic biopsy for retroperitoneal lymph node swe...
562069 - Observations on the surface area of the abnormal transformation zone associated with in...
865729 - Colposcopic evaluation of patients with abnormal cervical cytology.
3815839 - Cervical pathology in young patients.
16948289 - Development and testing of a new outcome measure of relationship between patients with ...
18160419 - Discrepancies between the eular response criteria and the nice guidelines for continuat...
10926809 - Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelia...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-22
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  -     ISSN:  1365-2036     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cellular plasticity: the good, the bad, and the ugly? Microenvironmental influences on progenitor ce...
Next Document:  Basolateral amygdala encodes upcoming errors but not response conflict.